{"entity":{"id":"specicare","kind":"company","name":"SpeciCare","aka":[],"tldr":"SpeciCare preserves a patient's living tumour tissue at biopsy or surgery so it can be used later for testing, including treatments that may not exist yet; patients can order it themselves.","summary":"SpeciCare is a US service that arranges for a patient's tumour tissue to be preserved alive at the time of biopsy or surgery, rather than fixed and discarded, so that functional drug testing, organoid growth or future therapies can use it. Future of Cancer Care Today lists it as patient-orderable.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://specicare.com/"},{"label":"Listed on Future of Cancer Care Today (Sijbrandij Foundation)","url":"https://sijbrandijfoundation.org/fcct"}],"tags":["ctgov-sponsor","fcct-directory"],"related":[],"cancers":[],"sections":[],"technologies":["functional-drug-testing","organoids"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"United States (city not published)","country":"US","companyType":"cro-services","website":"https://specicare.com/","investors":[],"funding":[]},"route":"/companies/specicare/","neighbours":{"technology":[{"id":"functional-drug-testing","kind":"technology","name":"Functional (ex vivo) drug testing","route":"/technologies/functional-drug-testing/"},{"id":"organoids","kind":"technology","name":"Patient-derived organoids","route":"/technologies/organoids/"}]}}